Showing 11 posts of 11 posts found.


Drugmakers colluded to drive up price of anti-nausea drug by 700%

May 23, 2019
Business Services, Medical Communications Business, NHS, collusion, competition, pharma

Four pharmaceutical firms have been accused of illegally colluding to restrict the supply of anti-nausea medication Prochlorperazine after the price …


Pharma execs testify in front of Senate of rising drug prices

February 27, 2019
Research and Development Business, Senate hearing, USA, pharma, sfc

Senior Executives from seven major pharmaceutical companies, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck & Co., Pfizer, Sanofi and Johnson & …

AstraZeneca to retire MedImmune brand amid restructuring

February 15, 2019
Medical Communications AstraZeneca, Business, MedImmune, R&D, biologics, restructuring

AstraZeneca is retiring the MedImmune brand as part of a restructuring that will see biologics integrated into two new R&D …


Top Ten most popular articles on of 2018!

December 21, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Business, biosimilars, brexit, pharma, top 10

Brexit, business and biosimilars, seemed to be the three themes of 2018. As Brexit negotiations reached a stalemate the pharmaceutical …


Novartis CEO calls for cultural shift to cater for millennial generation

December 7, 2018
Medical Communications Business, company, culture, millenials. Novartis

The CEO of Swiss multinational Novartis has said that he wants to ‘un-boss’ the multi-billion pound company while relaxing the …


Novartis denies potential split with Sandoz

November 15, 2018
Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers

Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …


Samsung BioLogics delisted over accounting violations

November 14, 2018
Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea

South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …


Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …

Biogen to spin off its haemophilia business

May 4, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Biogen, Business, alprolix, eloctate, haemophilia, hemophilia, spin off, spin-off

Biogen (NASDAQ: BIIB) has announced plans to spin off its haemophilia business as an independent, publicly traded company. To be …

Pfizer picture

Pfizer sells nutrition business to Nestlé for $11.9 billion

April 23, 2012
Business Services, Sales and Marketing Business, Lipitor, Pfizer, nestle, nutrition

Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …

Financial Reporting – it’s all a foreign language… literally!

March 18, 2011
Business Services Audits, Business, Financial, Languages, Reports, Services, TranslateMedia, tax, translation

Over the last two decades technology has allowed companies to greatly increase their global reach. Within the pharmaceutical sector it …

Latest content